The study by Wu et al. supported the idea that methylation markers (cg10272601 in WNK2, cg12680131 in TPO and cg22511877 in MYT1L) in white blood cell DNA can serve as biomarkers of HCC susceptibility [63]. The gene discussed is MYT1L; the disease is hepatocellular carcinoma.